Nine recent clinical studies with over 11,314 patients show that devices with EnduraLife™ Battery Technology are lasting longer than comparable devices from both Medtronic and St. Jude Medical.1-9
PDF ( 364.0 KB )
This 6-year follow-up study shows divergence in battery longevity between Boston Scientific and St. Jude Medical beginning around year 5, with Boston Scientific having significantly higher device survival rate for CRT-D devices through year 6.
PDF ( 223.0 KB )
A multi-center, retrospective observational study with data collected from 710 patients showed that battery capacity (Ah) is a useful predictor of device longevity, and Boston Scientific devices, with a usable battery capacity of 2.0 Ah, last significantly longer than Medtronic or St. Jude Medical devices.
PDF ( 197.0 KB )
This independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds of patients implanted with CRT-ICDs from January 1, 2007, to October 31, 2013, found that Boston Scientific CRT-Ds last significantly longer than Medtronic CRT-Ds.
PDF ( 198.0 KB )
Explore the results of an independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds. The results are from a non-academic community hospital (NCH), which may have substantial differences in age, gender and comorbidities than those in academic centers and national trials.
PDF ( 216.0 KB )
This independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-D) found that Boston Scientific’s modern CRT-Ds have the lowest risk of replacement at 5 years.
PDF ( 208.0 KB )
See the results of this independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-Ds) of all patients implanted with CRT-ICDs from 2008 through 2009 at Royal Victoria Hospital in Belfast, Northern Ireland.
PDF ( 353.0 KB )
The largest study to investigate multiple manufacturer ICD longevity to date, conducted with data from two large European centers, confirms Boston Scientific as the longevity leader across VR, DR and CRT ICDs.
Sign up to receive periodic emails about device longevity and how it impacts
patients, payers and the healthcare system.
